Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate Safety and Effectiveness of RINVOQ in Adult Participants With Ankylosing Spondylitis in the Real-World Japan (SELECT AXIS RW)

NCT05609643 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT05609643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05609643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate Safety and Effectiveness of RINVOQ in Adult Participants With Ankylosing Spondylitis in the Real-World Japan (SELECT AXIS RW)
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
July 6, 2022
Completion date
January 29, 2026
Enrollment
69 (actual)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis